对国家基本药物集中采购价格政策的逆向思考与建议

裴泽军; 孙欣

doi:10.3969/j.issn.1006-0111.2014.04.019

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿，请务必投稿前电话或邮箱咨询。联系电话：021-81871323，邮箱：yxsjzzs@163.com。敬请谅解，谢谢配合！

《药学实践与服务》编辑部

重要通知

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，或填写编委登记申请表的，请谨防诈骗！

编辑部用于作者校稿时微信绑定的邮件是通过官方邮箱：yxsjzzs@163.com发送的，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开！如有疑虑，请联系编辑部，电话：021-81871323。

《药学实践与服务》编辑部

对国家基本药物集中采购价格政策的逆向思考与建议

裴泽军, 孙欣

文章导航 > 药学实践与服务 > 2014 > 32(4): 304-306

裴泽军, 孙欣. 对国家基本药物集中采购价格政策的逆向思考与建议[J]. 药学实践与服务, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

引用本文:

裴泽军, 孙欣. 对国家基本药物集中采购价格政策的逆向思考与建议[J]. 药学实践与服务, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

PEI Zejun, SUN Xin. The opposite thought and advice for the price policy of centralized purchasing in national essential drugs[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

Citation:

PEI Zejun, SUN Xin. The opposite thought and advice for the price policy of centralized purchasing in national essential drugs[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

对国家基本药物集中采购价格政策的逆向思考与建议

doi: 10.3969/j.issn.1006-0111.2014.04.019

裴泽军,
孙欣

无锡市第二人民医院, 江苏无锡 214002

The opposite thought and advice for the price policy of centralized purchasing in national essential drugs

PEI Zejun,
SUN Xin

Wuxi Second People's Hospital, Wuxi, 214002, China

摘要: 目的解析基本药物集中采购过程中存在主要问题及其原因,并针对价格问题提出有效的解决方案,以确保基本药物的质量与正常供应,有效降低患者负担,保障患者用药安全。方法对6家三级医院的基本药物集中采购实施情况进行调查,对存在主要突出问题进行归纳分析,找出其内在原因并提出相应解决方案。结果基本药物集中采购工作进展较顺利,但在实施过程中也存在因实行最低价中标原则导致部份产品价格过低而产生药品质量与药品供应难以保障等诸多问题。结论基本药物集中采购的价格政策不能简单地以最低价中标,而应当科学地、全面地分析制定策略。建议实行平均价格区间内低价中标,适当放宽差率控制,既能降低药品价格,也能避免恶性竞争,药品质量和生产供应也得到保障,同时医疗机构也愿意更多地使用,从而真正减轻患者负担,缓解看病贵的难题。
- 基本药物 /
- 集中采购 /
- 价格政策 /
- 逆向思考
Abstract: Objective To analysis the major problems and the causes in the process of centralized purchasing of national essential drugs, and to give some effective solutions according to the price problems for ensuring the quality and regular supply of national essential drugs, decrease patients burden effectively and safeguard the medication safety of patients. Methods The implementation of centralized purchasing of national essential drugs was investigated, the problems which were major and outstanding were analyzed to find out the internal causes and the effective solutions were given. Results The progression of centralized purchasing of national essential drugs was successfully in general.The implementation of the principle of winning of the bidding with the lowest bid price lead to excessive low price, which caused some problems such as lower quality or bad supplied of some national essential drugs. Conclusion The price policy of centralized purchasing of national essential drugs should not be instituted based on the lower price, more winning of biddings.It needed more scientific and overall perspective thoughts.It maybe solve the problems mentioned above by winning of the bidding with the lowest bid price in the interval average price, appropriately loosing the control of difference rate with the results of decreasing the drug price, avoiding cut-throat competition, ensuring the quality and supply of drugs, lightening the patients' burden, releasing the problem of high cost of getting medical treatment.
- national essential drugs /
- centralized purchasing /
- price policy, opposite thought /

[1]	张先洲,宋金春.国家基本药物制度与国家基本药物目录介绍[J].中国医院药学杂志,2009,23(29):2037.
[2]	高军,候玉岭.基本药物招标采购要回归"质量优先,价格合理"原则[J].首都医药,2012,7:22.
[3]	沈清.基本药物制度尚有难题待解[J].中国卫生,2012,3:77.
[4]	王思欧,刘洋,管晓东.我国部分地区基本药物价格水平实证研究[J].中国卫生事业,2011,4:266.
[5]	郑益川,张黎明,方云芬,等,药品零差率与免费部分基本药物试点的实践[J].中华医院管理杂志,2011,7(27):556.

[1]	吴友根, 顾妤婷, 夏菊, 钱庆庆. 长三角区域药物临床试验运行管理问题的调查研究 . 药学实践与服务, 2026, 44(2): 103-107. doi: 10.12206/j.issn.2097-2024.202311002
[2]	王旭昉, 王彦婷, 姚春萌, 陆斌. 乳酸菌作为重组蛋白药物递送载体的研究 . 药学实践与服务, 2026, 44(1): 7-11. doi: 10.12206/j.issn.2097-2024.202309021
[3]	李倩, 王荣, 杨峰, 王晓锋, 尹东锋. 高原低氧对药物代谢的影响及机制研究进展 . 药学实践与服务, 2026, 44(): 1-5. doi: 10.12206/j.issn.2097-2024.202403018
[4]	姜建芳, 王思平, 何新军. 硝苯地平在高血压孕妇中的药物毒性：基于FAERS数据库的真实世界研究 . 药学实践与服务, 2025, 43(6): 307-312. doi: 10.12206/j.issn.2097-2024.202501001
[5]	陈明, 王晨佳, 唐原君, 汪硕闻, 范国荣. 呋喹替尼的治疗药物监测方法构建及其临床应用 . 药学实践与服务, 2025, 43(12): 610-613. doi: 10.12206/j.issn.2097-2024.202412043
[6]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2025, 43(12): 614-618. doi: 10.12206/j.issn.2097-2024.202402034
[7]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2025, 43(1): 26-29, 40. doi: 10.12206/j.issn.2097-2024.202404034
[8]	蔺淼, 费永和, 崔俐俊, 陈静. 中国创新药械政策进展与思考 . 药学实践与服务, 2025, 43(11): 577-582. doi: 10.12206/j.issn.2097-2024.202504055
[9]	李锐, 张倩倩, 王瑞冬, 高小峰. 国家集中带量采购政策下样本医院良性前列腺增生治疗药物使用情况分析 . 药学实践与服务, 2025, 43(1): 41-46. doi: 10.12206/j.issn.2097-2024.202408031
[10]	杜月, 李嘉莉, 柴昱, 陈少卿, 战旗. 多家儿童专科医院用药情况分析 . 药学实践与服务, 2025, 43(12): 631-636. doi: 10.12206/j.issn.2097-2024.202404071
[11]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[12]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[13]	何亚伦, 祁智, 常杰. 消胀通便膏在晚期肝癌患者阿片类药物相关性便秘中的应用研究 . 药学实践与服务, 2024, 42(12): 520-523. doi: 10.12206/j.issn.2097-2024.202309009
[14]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[15]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[16]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[17]	费永和, 崔俐俊, 陈静. 应急状态下药品专利强制许可的几点思考 . 药学实践与服务, 2024, 42(7): 310-314. doi: 10.12206/j.issn.2097-2024.202309047
[18]	瞿文君, 白若楠, 崔力, 周琰. 基于联合库存的公立医院多院区药品采购模式分析 . 药学实践与服务, 2024, 42(7): 315-318. doi: 10.12206/j.issn.2097-2024.202401002

点击查看大图

计量

文章访问数: 3848
HTML全文浏览量: 275
PDF下载量: 92
被引次数: 0

对国家基本药物集中采购价格政策的逆向思考与建议

doi: 10.3969/j.issn.1006-0111.2014.04.019

裴泽军,
孙欣

无锡市第二人民医院, 江苏无锡 214002

收稿日期: 2012-12-27
修回日期: 2013-05-29

关键词:

摘要: 目的解析基本药物集中采购过程中存在主要问题及其原因,并针对价格问题提出有效的解决方案,以确保基本药物的质量与正常供应,有效降低患者负担,保障患者用药安全。方法对6家三级医院的基本药物集中采购实施情况进行调查,对存在主要突出问题进行归纳分析,找出其内在原因并提出相应解决方案。结果基本药物集中采购工作进展较顺利,但在实施过程中也存在因实行最低价中标原则导致部份产品价格过低而产生药品质量与药品供应难以保障等诸多问题。结论基本药物集中采购的价格政策不能简单地以最低价中标,而应当科学地、全面地分析制定策略。建议实行平均价格区间内低价中标,适当放宽差率控制,既能降低药品价格,也能避免恶性竞争,药品质量和生产供应也得到保障,同时医疗机构也愿意更多地使用,从而真正减轻患者负担,缓解看病贵的难题。

English Abstract

The opposite thought and advice for the price policy of centralized purchasing in national essential drugs

PEI Zejun,
SUN Xin

Wuxi Second People's Hospital, Wuxi, 214002, China

Received Date: 2012-12-27
Rev Recd Date: 2013-05-29

Keywords:

Abstract: Objective To analysis the major problems and the causes in the process of centralized purchasing of national essential drugs, and to give some effective solutions according to the price problems for ensuring the quality and regular supply of national essential drugs, decrease patients burden effectively and safeguard the medication safety of patients. Methods The implementation of centralized purchasing of national essential drugs was investigated, the problems which were major and outstanding were analyzed to find out the internal causes and the effective solutions were given. Results The progression of centralized purchasing of national essential drugs was successfully in general.The implementation of the principle of winning of the bidding with the lowest bid price lead to excessive low price, which caused some problems such as lower quality or bad supplied of some national essential drugs. Conclusion The price policy of centralized purchasing of national essential drugs should not be instituted based on the lower price, more winning of biddings.It needed more scientific and overall perspective thoughts.It maybe solve the problems mentioned above by winning of the bidding with the lowest bid price in the interval average price, appropriately loosing the control of difference rate with the results of decreasing the drug price, avoiding cut-throat competition, ensuring the quality and supply of drugs, lightening the patients' burden, releasing the problem of high cost of getting medical treatment.

裴泽军, 孙欣. 对国家基本药物集中采购价格政策的逆向思考与建议[J]. 药学实践与服务, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

引用本文:

裴泽军, 孙欣. 对国家基本药物集中采购价格政策的逆向思考与建议[J]. 药学实践与服务, 2014, 32(4): 304-306. doi: 10.3969/j.issn.1006-0111.2014.04.019

Citation: